Work

Advances in omics for informed pharmaceutical research and development in the era of systems medicine

Year: 2017

Type: editorial

Abstract: In the era of systems medicine, the pathological networks, mutated genes and associated aberrant pathways, and a drug’s actions to rectify the abnormalities, of a disease are integrated across the ...

Source: Expert Opinion on Drug Discovery

DOI: 10.1080/17460441.2018.1394839

Authors: Jane P. F. Bai, Ioannis N. Melas, Junguk Hur, Ellen Guo

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, UCB Pharma (United Kingdom), University of North Dakota, University of Illinois Chicago

Language: English

Topic: Bioinformatics and Genomic Networks

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2765495003

Cites: 12

Cited by: 15

Related to: 10